Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ascharya K. Balaji
Observed name:
Ascharya Balaji
Institution:
University at Buffalo, State University of New York
Observed institutions:
National Cancer Institute,
Center for Cancer Research,
University at Buffalo, State University of New York
ORCID:
0000-0003-1382-5864
Observed ORCID:
0000-0003-1382-5864
OpenAlex ID:
A5042463183
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
2021
·
Diwakar Davar
, Amiran K. Dzutsev
, et al.
·
Science
·
1,935
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
2022
·
John A. McCulloch
, Diwakar Davar
, et al.
·
Nature Medicine
·
521
PDF
JAMS - A framework for the taxonomic and functional exploration of microbiological genomic data
2023
·
John A. McCulloch
, Jonathan H. Badger
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
16
PDF
Abstract LB062: Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma
2021
·
Diwakar Davar
, Amiran Dzutsev
, et al.
·
Cancer Research
·
5
Y-Shaped Versus Linear Duraplasty Technique in Posterior Fossa Decompression for Treatment of Chiari Malformation Type I: A Propensity Score-Matched Comparative Study
2025
·
Matthew J. Recker
, Bernard K. Okai
, et al.
·
Operative Neurosurgery
Show more works
View as search
Works count:
5
Citation count:
2,477
H-index:
4
I10-index:
3
Year
Topic
Type